SYNTHESIS OF NEW BIOACTIVE COMPOUNDS BASED ON ORGANIC CHEMISTRY AND THEIR PROSPECTS FOR APPLICATION IN PHARMACEUTICALS

407 Volume 5, Issue 10: Special Issue (EJAR) ISSN: 2181-2020 MPHAPP THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE “MODERN PHARMACEUTICS: ACTUAL PROBLEMS AND PROSPECTS” TASHKENT, OCTOBER 17, 2025 in-academy.uz SYNTHESIS OF NEW BIOACTIVE COMPOUNDS BASED ON ORGANIC CHEMISTRY AND THEIR PROSPECTS FOR APPLICATION IN PHARMACEUTICALS Zaripova.R.Sh. Yakubov.Sh.U. Tashkent pharmaceutical institutie, city Tashkent, Uzbekistan. e-mail: yaqubovshohzodbek, tel: +998911902767 https://doi.org/10.5281/zenodo.17340720 Introduction to Bioactive Compounds and Organic Chemistry The intersection of bioactive compounds and organic chemistry serves as a cornerstone in the advancement of pharmaceutical applications, offering a comprehensive understanding of how natural and synthetic substances can interact within biological systems. Bioactive compounds, which are pivotal in developing therapeutic agents, possess the ability to bring about significant biochemical changes. Organic chemistry, with its focus on the structure, properties, and reactions of carbon-containing compounds, provides the necessary framework for synthesizing new bioactive agents. Recent developments in natural products chemistry, particularly techniques like high-resolution screening and miniaturization of assays, are revolutionizing how these compounds are identified and tested for efficacy. These innovations facilitate the discovery of novel drugs while improving the efficiency of bioassay-guided fractionation processes, thereby enhancing productivity in pharmaceutical research. As the field progresses, the synergy between organic chemistry and bioactive compounds will remain integral to meeting healthcare challenges and fostering drug development. Methods for the Synthesis of New Bioactive Compounds. The synthesis of new bioactive compounds is fundamentally shaped by various organic chemistry methodologies that emphasize efficiency and specificity. Traditional methods, such as extraction from natural sources, provide a foundation for identifying bioactive constituents; however, contemporary synthetic strategies, including combinatorial chemistry and high-throughput screening, have revolutionized the process. These approaches allow for the rapid generation of diverse chemical libraries, facilitating the discovery of potential pharmaceuticals. Additionally, the incorporation of advanced computational techniques enhances the prediction of molecular behavior and interaction, streamlining the identification of lead compounds that warrant further exploration. The reliance on chemical fingerprinting to assess molecular similarity has also been instrumental, as it enables researchers to efficiently navigate large chemical databases in search of compounds with desirable activity profiles. Furthermore, leveraging insights from marine biochemistry has introduced innovative avenues for synthesis, reflecting the growing intersection of marine resources and organic chemistry in the quest for novel therapeutics. Applications and Prospects in the Pharmaceutical Industry. The pharmaceutical industry is increasingly recognizing the importance of bioactive compounds derived from organic chemistry, which hold significant promise for novel therapeutic applications. Recent advancements have improved methods for isolating and identifying these compounds, enhancing the efficiency of drug discovery processes. Techniques such as high-resolution screening, which couples chromatography with biochemical assays, enable researchers to detect bioactive constituents directly within complex plant extracts, thereby facilitating more reliable identification without traditional isolation methods. This capability is pivotal, particularly in discovering new pharmaceutical leads, as highlighted by the evolution of natural product chemistry in the past few years, including innovations like miniaturized 408 Volume 5, Issue 10: Special Issue (EJAR) ISSN: 2181-2020 MPHAPP THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE “MODERN PHARMACEUTICS: ACTUAL PROBLEMS AND PROSPECTS” TASHKENT, OCTOBER 17, 2025 in-academy.uz assays and high-throughput screening technologies. Moreover, the integration of marine biotechnology into pharmaceutical research further expands the potential of bioactive compounds, demonstrating the need for collaborative efforts in marine science and medicine to leverage these emerging biopharmaceutical opportunities. Conclusion. In conclusion, the synthesis of new bioactive compounds grounded in organic chemistry presents a transformative opportunity for pharmaceutical applications, as evidenced by the exploration of diverse natural products and innovative nanoparticle strategies. The extensive potential for novel therapeutic leads lies in the vast reservoir of biodiversity, which has historically underpinned drug discovery and development. As articulated in, harnessing the medicinal properties of plants remains crucial; however, there are significant challenges, such as optimizing highthroughput screening bioassays and securing the supply of bioactive molecules. Concurrently, advancements in smart nanoparticles, capable of precise drug delivery and tumor targeting, as discussed in, pave the way for more personalized and effective cancer treatments. Thus, interdisciplinary collaboration in synthesis, discovery, and drug development will be essential for overcoming these obstacles and fully realizing the promise of new bioactive compounds in modern medicine.